These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21762997)

  • 1. Hallucinatory delirium following use of MDPV: "Bath Salts".
    Penders TM; Gestring R
    Gen Hosp Psychiatry; 2011; 33(5):525-6. PubMed ID: 21762997
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylenedioxypyrovalerone ("bath salts"), related death: case report and review of the literature.
    Kesha K; Boggs CL; Ripple MG; Allan CH; Levine B; Jufer-Phipps R; Doyon S; Chi P; Fowler DR
    J Forensic Sci; 2013 Nov; 58(6):1654-9. PubMed ID: 23822613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor--Methylenedioxypyrovalerone as a cause of excited delirium.
    Penders TM; Gestring RE
    J Forensic Sci; 2014 May; 59(3):869. PubMed ID: 24749855
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature.
    Desharnais B; Dazé Y; Huppertz LM; Mireault P; Skinner CD
    Forensic Sci Med Pathol; 2017 Sep; 13(3):350-354. PubMed ID: 28668987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone ("bath salts").
    Penders TM; Lang MC; Pagano JJ; Gooding ZS
    J ECT; 2013 Dec; 29(4):e59-60. PubMed ID: 23609518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deaths involving methylenedioxypyrovalerone (MDPV) in Upper East Tennessee.
    Wright TH; Cline-Parhamovich K; Lajoie D; Parsons L; Dunn M; Ferslew KE
    J Forensic Sci; 2013 Nov; 58(6):1558-62. PubMed ID: 23919452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations.
    Diestelmann M; Zangl A; Herrle I; Koch E; Graw M; Paul LD
    Forensic Sci Int; 2018 Feb; 283():72-84. PubMed ID: 29275216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer drugs in psychiatric practice - a review of the literature and the recent situation in Hungary.
    Szily E; Bitter I
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):223-31. PubMed ID: 24380963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Designer drug induced psychosis].
    Fullajtar M; Ferencz C
    Neuropsychopharmacol Hung; 2012 Jun; 14(2):137-40. PubMed ID: 22710853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (methylone), and Caffeine in Rats.
    Gannon BM; Galindo KI; Mesmin MP; Rice KC; Collins GT
    Neuropsychopharmacology; 2018 Mar; 43(4):761-769. PubMed ID: 28677665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute psychosis induced by bath salts: a case report with clinical and forensic implications.
    Stoica MV; Felthous AR
    J Forensic Sci; 2013 Mar; 58(2):530-3. PubMed ID: 23317451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland.
    Kriikku P; Rintatalo J; Pihlainen K; Hurme J; Ojanperä I
    Int J Legal Med; 2015 Jul; 129(4):741-9. PubMed ID: 25833171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases.
    Antonowicz JL; Metzger AK; Ramanujam SL
    Gen Hosp Psychiatry; 2011; 33(6):640.e5-6. PubMed ID: 21749840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Illicit bath salts: not for bathing.
    Kyle PB; Iverson RB; Gajagowni RG; Spencer L
    J Miss State Med Assoc; 2011 Dec; 52(12):375-7. PubMed ID: 22329114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).
    Murray BL; Murphy CM; Beuhler MC
    J Med Toxicol; 2012 Mar; 8(1):69-75. PubMed ID: 22271565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity.
    Colon-Perez LM; Tran K; Thompson K; Pace MC; Blum K; Goldberger BA; Gold MS; Bruijnzeel AW; Setlow B; Febo M
    Neuropsychopharmacology; 2016 Aug; 41(9):2352-65. PubMed ID: 26997298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current "legal highs".
    Johnson LA; Johnson RL; Portier RB
    J Emerg Med; 2013 Jun; 44(6):1108-15. PubMed ID: 23528960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clean but not sober: a 16-year-old with restlessness.
    Osterhoudt KC; Cook MD
    Pediatr Emerg Care; 2011 Sep; 27(9):892-4. PubMed ID: 21926895
    [No Abstract]   [Full Text] [Related]  

  • 19. Are "bath salts" the next generation of stimulant abuse?
    Winder GS; Stern N; Hosanagar A
    J Subst Abuse Treat; 2013 Jan; 44(1):42-5. PubMed ID: 22445773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of disseminated intravascular coagulation due to "bath salts" resulting in fatalities, with laboratory confirmation.
    Young AC; Schwarz ES; Velez LI; Gardner M
    Am J Emerg Med; 2013 Feb; 31(2):445.e3-5. PubMed ID: 22867829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.